Aralez Pharmaceuticals Inc (ARZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
23 Pages - GLDATA62657
$250.00

Summary

Aralez Pharmaceuticals Inc (Aralez Pharma) focuses on the development and commercialization of therapeutic drugs. The company offers products in the fields of cardiovascular diseases, pain management, dermatology and gastrointestinal, other areas. Its pain management products include Fiorinal and Fiorinal C, among others. Aralez Pharma also offers non prescription products for women’s health. The company’s pipeline products are yasprala and MT400. Aralez Pharma in collaboration with other companies commercializes the products to customers across various regions that include Europe, the US and Canada. The company has its presence in New Jersey, the US and Dublin, Ireland. Aralez Pharma is headquartered in Milton, Ontario, Canada.

Aralez Pharmaceuticals Inc (ARZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Aralez Pharma Acquires US Rights to Toprol-XL and Authorized Generic from AstraZeneca 10
Aralez Pharma Acquires US and Canadian rights to Zontivity from Merck 11
Venture Financing 12
Aralez Pharma Secures USD75 Million in Venture Debt Financing 12
Partnerships 13
Biohit Enters Into Distribution Agreement With Medical Futures 13
Cipher Pharma Enters Into Distribution Agreement With Medical Futures 14
Licensing Agreements 15
Faes Farma Enters into Licensing Agreement with Aralez Pharma 15
Norgine Expands Licensing Agreement With Medical Futures For NORMACOL 15
Apricus Biosciences Enters Into Licensing Agreement with Aralez Pharma 16
Equity Offering 17
Aralez Pharma Raises USD45 Million in Private Placement of Shares 17
Acquisition 18
Tribute Pharma Acquires Medical Futures for USD20 Million 18
Aralez Pharmaceuticals Inc - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 1
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aralez Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aralez Pharma Acquires US Rights to Toprol-XL and Authorized Generic from AstraZeneca 10
Aralez Pharma Acquires US and Canadian rights to Zontivity from Merck 11
Aralez Pharma Secures USD75 Million in Venture Debt Financing 12
Biohit Enters Into Distribution Agreement With Medical Futures 13
Cipher Pharma Enters Into Distribution Agreement With Medical Futures 14
Faes Farma Enters into Licensing Agreement with Aralez Pharma 15
Norgine Expands Licensing Agreement With Medical Futures For NORMACOL 15
Apricus Biosciences Enters Into Licensing Agreement with Aralez Pharma 16
Aralez Pharma Raises USD45 Million in Private Placement of Shares 17
Tribute Pharma Acquires Medical Futures for USD20 Million 18
Aralez Pharmaceuticals Inc, Key Competitors 20
Aralez Pharmaceuticals Inc, Key Employees 21
Aralez Pharmaceuticals Inc, Other Locations 22
Aralez Pharmaceuticals Inc, Subsidiaries 22

List of Figures
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aralez Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838